Pancreatic Transdifferentiation Using β-Cell Transcription Factors for Type 1 Diabetes Treatment

Type 1 diabetes is a chronic illness in which the native beta (β)-cell population responsible for insulin release has been the subject of autoimmune destruction. This condition requires patients to frequently measure their blood glucose concentration and administer multiple daily exogenous insulin i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahoney, Alexandra L. G., Nassif, Najah T., O’Brien, Bronwyn A., Simpson, Ann M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315695/
https://www.ncbi.nlm.nih.gov/pubmed/35883588
http://dx.doi.org/10.3390/cells11142145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315695/
https://www.ncbi.nlm.nih.gov/pubmed/35883588
http://dx.doi.org/10.3390/cells11142145

Ejemplares similares